CN107693599A - A kind of combination ointment for treating qi depression to blood stasis myelopathy - Google Patents
A kind of combination ointment for treating qi depression to blood stasis myelopathy Download PDFInfo
- Publication number
- CN107693599A CN107693599A CN201610488945.1A CN201610488945A CN107693599A CN 107693599 A CN107693599 A CN 107693599A CN 201610488945 A CN201610488945 A CN 201610488945A CN 107693599 A CN107693599 A CN 107693599A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood stasis
- depression
- ointment
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008280 blood Substances 0.000 title claims abstract description 24
- 210000004369 blood Anatomy 0.000 title claims abstract description 24
- 206010028570 Myelopathy Diseases 0.000 title claims abstract description 9
- 239000002674 ointment Substances 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 8
- 241000758794 Asarum Species 0.000 claims abstract description 5
- 241000255789 Bombyx mori Species 0.000 claims abstract description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 5
- 241000195947 Lycopodium Species 0.000 claims abstract description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 5
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 4
- 241000112528 Ligusticum striatum Species 0.000 claims description 4
- 244000046146 Pueraria lobata Species 0.000 claims description 3
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 210000003205 muscle Anatomy 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 230000002040 relaxant effect Effects 0.000 abstract description 5
- 210000002435 tendon Anatomy 0.000 abstract description 5
- 230000000202 analgesic effect Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 206010019233 Headaches Diseases 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- DCTLJGWMHPGCOS-UHFFFAOYSA-N Osajin Chemical compound C1=2C=CC(C)(C)OC=2C(CC=C(C)C)=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DCTLJGWMHPGCOS-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- OUZCFMSJGDEXRT-UHFFFAOYSA-N Scandinone Natural products O=C1C=2C(OC)=C(CC=C(C)C)C=3OC(C)(C)C=CC=3C=2OC=C1C1=CC=C(O)C=C1 OUZCFMSJGDEXRT-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- -1 cellas Natural products 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- BCZFSDNVXODRAJ-JTTNIQEDSA-N lycopodine Chemical compound C1CCN2CCC[C@@H]3[C@H]4C[C@@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-JTTNIQEDSA-N 0.000 description 1
- BCZFSDNVXODRAJ-ZHMBSYLPSA-N lycopodine Natural products C1CCN2CCC[C@@H]3[C@H]4C[C@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-ZHMBSYLPSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of combination ointment for treating qi depression to blood stasis myelopathy, belongs to technical field of traditional Chinese medicine preparation.It is mainly made up of 10 kinds of bulk drugs such as bark of ash, peach kernel, lycopodium calvatum, asarum, cassia twig, larva of a silkworm with batrytis, ointment external application is made puts on the skin and smear affected part.The present invention have it is promoting blood circulation and removing blood stasis, dredge the channels, relaxing muscles and tendons analgesic function, treatment qi depression to blood stasis myelopathy effect it is good, put on the skin smear conveniently, safely and effectively.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation.
Background technology
Qi stagnation and blood stasis type patient with cervical Spondylopathy has a headache, neck, shoulder, the back of the body and limbs pain, numb, and fixed pain, night aggravates, head
Dizzy dim eyesight, blurred vision, insomnia forgetfulness are fidgety.Tongue nature is purple, dark or have ecchymosis, and the more strings of arteries and veins are thin or thin puckery.Modern medicine is right at present
The treatment of this disease there is no special effective treatment method.
The content of the invention
The purpose of the present invention is overcome the deficiencies in the prior art, there is provided it is a kind of treat qi depression to blood stasis myelopathy combination it is soft
Cream.It has promoting blood circulation and removing blood stasis, dredges the channels, the function of relaxing muscles and tendons analgesic.It is good to treat qi depression to blood stasis myelopathy effect.It can reach and put on the skin
Smear conveniently, safely and effectively purpose.
The technical solution adopted for the present invention to solve the technical problems is by bark of ash, peach kernel, lycopodium calvatum, Radix Angelicae Sinensis, Ligusticum wallichii, Pueraria lobota
10 kinds of root, notopterygium root, asarum, cassia twig, larva of a silkworm with batrytis bulk drugs are formed.
About drug ingedient major function and preparation in invention formulation.
Bark of ash in the present invention, it is bitter in taste, pungent, put down.The first, second of alkaloid containing bark of ash, third, volatile oil etc..Wind clearing damp is dissipated, it is living
Blood relaxing muscles and tendons.Arthralgia pain due to rheumatism is cured mainly, muscles and bones contraction, jaundice, is had blood in stool, osteopyrexia and fever.
Peach kernel in the present invention, it is bitter in taste, it is sweet, put down.Containing amygdalin, cellas, vitamin, fat oil etc..Blood-breaking row
The stasis of blood, moisturize laxation.Cure mainly storage blood to go mad, traumatic injury, the dry constipation of blood, Amenorrhea, abdominal mass, wandering arthritis, malaria, extravasated blood swelling and pain.
Lycopodium calvatum in the present invention, nature and flavor are pungent, bitter, temperature.Containing lycopodine, sterol, volatile oil etc..Relaxing tendons and activating collaterals, promoting blood circulation are dispelled
Wind, dehumidification swelling.Cure mainly extremities joint pain, paralysis of the limbs, sequelae of infantile paralysis, oedema, traumatic injury, tetraparesis.
Radix Angelicae Sinensis in the present invention, nature and flavor sweet, acrid, warm.Containing volatile oil, palmitic acid, sucrose, nicotinic acid, vitamin E etc..Enrich blood
Promoting blood circulation, blood stasis dispersing and fresh blood promoting, menstruation regulating are moisturized.Cure mainly deficiency of blood headache, Low Back Pain, all pains of trusted subordinate, dry feces, Impotence numbness, abdominal mass, ulcer Sore
Ulcer, Amenorrhea, menalgia, uterine bleeding.
Ligusticum wallichii in the present invention, nature and flavor are pungent, temperature.Containing volatile oil, phenolic constituent, interior lipid, forulic acid etc..Promote breath and open depression,
Dispel pathogenic wind and remove dampness, promoting blood circulation and stopping pain.Cure mainly air-cooled dizziness of having a headache, rib pain stomachache, arthritis muscle contraction, Amenorrhea, difficult labour, postpartum stasis block pain.
Ulcer sores.
The root of kudzu vine in the present invention, nature and flavor are sweet, pungent, put down.It is starch-containing, osajin, alkaloid etc..Expelling pathogenic factors from muscles and skin is brought down a fever, and is promoted the production of body fluid only
Yearningly.Cure mainly and have a headache and fever, rigid neck and back, polydipsia diarrhea, measles without adequate eruption.
Notopterygium root in the present invention, nature and flavor are pungent, bitter, temperature.Containing volatile oil.Inducing sweat and dispelling exogenous evils, search wind prevailing over dampness.Cure mainly cold,
Have a headache lossless, whole body podomere pain, arthralgia pain due to rheumatism.
Asarum in the present invention, nature and flavor are pungent, temperature.Containing volatile oil.Wind is dissipated, water-filling, is had one's ideas straightened out.Toothache is cured mainly, is had a headache, rheumatism numbness
Bitterly, sputum cough.
Cassia twig in the present invention, nature and flavor are pungent, sweet, temperature.Containing volatile oil.Sweating expelling pathogenic factors from muscles and skin, warming meridians and promoting circulation of qi.Chill table disease is cured mainly,
Shoulder arm podomere is ached, Amenorrhea abdomen pain etc..
The larva of a silkworm with batrytis in the present invention, nature and flavor are salty, pungent, put down.It is fatty, protein, ammonium oxalate.Wind-dispelling heat, relieving convulsion, wind-dispelling
Phlegm.Cure mainly frightened epilepsy, apoplexy twitch, headache, abscess of throat, aphonia, wind phlegm, scrofula etc..
The etiology and pathogenesis of qi depression to blood stasis myelopathy is deficient qi and blood cause qi depression to blood stasis, and channels and collaterals are cloudy stagnant and pathogenic.The present invention
With promoting blood circulation and removing blood stasis, dredge the channels, the function of relaxing muscles and tendons analgesic, treatment qi depression to blood stasis myelopathy effect is good.The present invention's is beneficial
Effect is clinic application proves that curative for effect, safe without toxic side effect.
Embodiment
1st, formula and part by weight：15 parts of bark of ash, 12 parts of peach kernel, 18 parts of lycopodium calvatum, 15 parts of Radix Angelicae Sinensis, 12 parts of Ligusticum wallichii, the root of kudzu vine
18 parts, 15 parts of notopterygium root, 6 parts of asarum, 18 parts of cassia twig, 15 parts of the larva of a silkworm with batrytis.
2nd, making and application method：Above-mentioned raw materials medicine is weighed in proportion and assorted, it is qualified to be processed with pharmaceutical equipment apparatus, carries
Pure concentration, which is made ointment external application and put on the skin, smears affected part.
Claims (1)
- A kind of 1. combination ointment for treating qi depression to blood stasis myelopathy, it is characterized in that formula and part by weight are 15 parts of bark of ash, peach 12 parts of benevolence, 18 parts of lycopodium calvatum, 15 parts of Radix Angelicae Sinensis, 12 parts of Ligusticum wallichii, 18 parts of the root of kudzu vine, 15 parts of notopterygium root, 6 parts of asarum, 18 parts of cassia twig, the larva of a silkworm with batrytis 15 parts；Above-mentioned raw materials medicine is weighed in proportion and assorted, it is qualified to be processed with pharmaceutical equipment apparatus, and purification concentration is made ointment external application and put on the skin Smear affected part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610488945.1A CN107693599A (en) | 2016-06-20 | 2016-06-20 | A kind of combination ointment for treating qi depression to blood stasis myelopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610488945.1A CN107693599A (en) | 2016-06-20 | 2016-06-20 | A kind of combination ointment for treating qi depression to blood stasis myelopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107693599A true CN107693599A (en) | 2018-02-16 |
Family
ID=61168629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610488945.1A Withdrawn CN107693599A (en) | 2016-06-20 | 2016-06-20 | A kind of combination ointment for treating qi depression to blood stasis myelopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107693599A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108465025A (en) * | 2018-06-07 | 2018-08-31 | 邵小宁 | It is a kind of treat cervical spondylosis, lumbar vertebra disease Chinese medicine composition and preparation method thereof |
-
2016
- 2016-06-20 CN CN201610488945.1A patent/CN107693599A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108465025A (en) * | 2018-06-07 | 2018-08-31 | 邵小宁 | It is a kind of treat cervical spondylosis, lumbar vertebra disease Chinese medicine composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107693599A (en) | A kind of combination ointment for treating qi depression to blood stasis myelopathy | |
| CN107510729A (en) | Treat and put water on the skin outside the animals and plants of qi depression to blood stasis myelopathy | |
| CN110237140A (en) | A kind of Eradicates necrotic tissue and promoting muscle growing Chinese medicine composition and preparation method thereof | |
| CN107510733A (en) | Treat the particle of qi depression to blood stasis myelopathy | |
| CN107510732A (en) | Treat the combination tincture of qi depression to blood stasis myelopathy | |
| CN107224461A (en) | Treat the combination outer applying liquid of the cold-dampness numbness type numbness of the skin | |
| CN107510730A (en) | A kind of decoction for oral administration for treating qi depression to blood stasis myelopathy | |
| CN107519257A (en) | A kind of tablet for treating pain in waist and lower extremities | |
| CN107296939A (en) | It is a kind of to treat putting on the skin for chill myelopathy and smear water | |
| CN106421073A (en) | Drug for treating chilblains and preparation method of drug | |
| CN107296844A (en) | A kind of tablet for treating chill myelopathy | |
| CN107519254A (en) | Treat the medicinal liquor of qi depression to blood stasis myelopathy | |
| CN107519448A (en) | A kind of pill for treating qi depression to blood stasis myelopathy | |
| CN107510731A (en) | Treat the washing lotion of becoming soaked with sweat of qi depression to blood stasis myelopathy | |
| CN107224475A (en) | A kind of animals and plants emulsifiable paste for treating the cold-dampness numbness type numbness of the skin | |
| CN107519255A (en) | Treat the external plaster of qi depression to blood stasis myelopathy | |
| CN107510725A (en) | A kind of tablet for treating qi depression to blood stasis myelopathy | |
| CN107224492A (en) | A kind of capsule preparations for treating the cold-dampness numbness type numbness of the skin | |
| CN103805439A (en) | Winter cherry wine with functions of dispelling wind and relieving pains and production method thereof | |
| CN107224491A (en) | A kind of condensed pill for treating the cold-dampness numbness type numbness of the skin | |
| CN107224476A (en) | A kind of tablet for treating the cold-dampness numbness type numbness of the skin | |
| CN107510827A (en) | Treat the external plaster of phlegm wet interlocking type cervical spondylopathy | |
| CN107519346A (en) | Liquid is put in a kind of combination for treating phlegm wet interlocking type cervical spondylopathy on the skin | |
| CN107510727A (en) | A kind of capsule preparations for treating qi depression to blood stasis myelopathy | |
| CN106806512A (en) | The animals and plants for the treatment of blood-dryness type wind-heat sores are put on the skin and smear water |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180216 |